{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"FDA OKs First-in-Human Trial for BGTC-Supported Rare Disease Gene Therapy","author_name":"techandbusiness.org · Policy","thumbnail_url":"https://nypost.com/wp-content/uploads/sites/2/2026/04/126306462.jpg?quality=75&strip=all&w=1200","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Policy</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/A9KxU337ELsycETkop5uYH\" style=\"color:#fff;text-decoration:none;\">FDA OKs First-in-Human Trial for BGTC-Supported Rare Disease Gene Therapy</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">The Food and Drug Administration on Thursday approved the first gene therapy for a rare inherited form of hearing loss, Regeneron announced. The treatment, called Otarmeni, is designed for people born...</p>\n    </blockquote>"}